Loading…
Sample size and power calculations in repeated measurement analysis
Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference betwee...
Saved in:
Published in: | Computer methods and programs in biomedicine 2001-02, Vol.64 (2), p.121-124 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3 |
container_end_page | 124 |
container_issue | 2 |
container_start_page | 121 |
container_title | Computer methods and programs in biomedicine |
container_volume | 64 |
creator | Ahn, Chul Overall, John E Tonidandel, Scott |
description | Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program. |
doi_str_mv | 10.1016/S0169-2607(00)00095-X |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70583439</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016926070000095X</els_id><sourcerecordid>525577</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3</originalsourceid><addsrcrecordid>eNqF0U1r3DAQBmBRGpptmp_QYiiE5uB2RrIk61TK0qSFQA5pIDchy7Og4q9KdkPy66PNLslxL6PLM5J4X8Y-InxFQPXtJg9TcgX6C8A5ABhZ3r1hK6w1L7VU8i1bvZBj9j6lvxlxKdU7doyIQqOpVmx94_qpoyKFRyrc0BbTeE-x8K7zS-fmMA6pCEMRaSI3U1v05NISqadhztx1DymkD-xo47pEp_vzhN1e_Pyz_lVeXV_-Xv-4Kn0lcS61qUzNkW9an6cGQcI70o6MdEZwgsYpUSvVeo3QKE3eCIFN3RBSDbwVJ-xsd-8Ux38Lpdn2IXnqOjfQuCSrQdaiEuYg5FgpBMUPQqxVxSVAhnIHfRxTirSxUwy9iw8WwW77sM992G3YFsA-92Hv8t6n_QNL01P7urUvIIPPe-BSDn0T3eBDenG1UQq36vtOUY73f6Bokw80eGpDJD_bdgwHPvIEiCSmAw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18642500</pqid></control><display><type>article</type><title>Sample size and power calculations in repeated measurement analysis</title><source>ScienceDirect Journals</source><creator>Ahn, Chul ; Overall, John E ; Tonidandel, Scott</creator><creatorcontrib>Ahn, Chul ; Overall, John E ; Tonidandel, Scott</creatorcontrib><description>Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program.</description><identifier>ISSN: 0169-2607</identifier><identifier>EISSN: 1872-7565</identifier><identifier>DOI: 10.1016/S0169-2607(00)00095-X</identifier><identifier>PMID: 11137194</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Biological and medical sciences ; Computer simulation ; Computerized, statistical medical data processing and models in biomedicine ; Controlled Clinical Trials as Topic - statistics & numerical data ; Dropouts ; Humans ; Medical sciences ; Medical statistics ; Numerical analysis ; Power calculation ; Repeated measures ; Sample Size ; Sample size estimate ; Schizophrenia - drug therapy ; Software</subject><ispartof>Computer methods and programs in biomedicine, 2001-02, Vol.64 (2), p.121-124</ispartof><rights>2001 Elsevier Science Ireland Ltd</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3</citedby><cites>FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=896614$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11137194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahn, Chul</creatorcontrib><creatorcontrib>Overall, John E</creatorcontrib><creatorcontrib>Tonidandel, Scott</creatorcontrib><title>Sample size and power calculations in repeated measurement analysis</title><title>Computer methods and programs in biomedicine</title><addtitle>Comput Methods Programs Biomed</addtitle><description>Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program.</description><subject>Biological and medical sciences</subject><subject>Computer simulation</subject><subject>Computerized, statistical medical data processing and models in biomedicine</subject><subject>Controlled Clinical Trials as Topic - statistics & numerical data</subject><subject>Dropouts</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Medical statistics</subject><subject>Numerical analysis</subject><subject>Power calculation</subject><subject>Repeated measures</subject><subject>Sample Size</subject><subject>Sample size estimate</subject><subject>Schizophrenia - drug therapy</subject><subject>Software</subject><issn>0169-2607</issn><issn>1872-7565</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqF0U1r3DAQBmBRGpptmp_QYiiE5uB2RrIk61TK0qSFQA5pIDchy7Og4q9KdkPy66PNLslxL6PLM5J4X8Y-InxFQPXtJg9TcgX6C8A5ABhZ3r1hK6w1L7VU8i1bvZBj9j6lvxlxKdU7doyIQqOpVmx94_qpoyKFRyrc0BbTeE-x8K7zS-fmMA6pCEMRaSI3U1v05NISqadhztx1DymkD-xo47pEp_vzhN1e_Pyz_lVeXV_-Xv-4Kn0lcS61qUzNkW9an6cGQcI70o6MdEZwgsYpUSvVeo3QKE3eCIFN3RBSDbwVJ-xsd-8Ux38Lpdn2IXnqOjfQuCSrQdaiEuYg5FgpBMUPQqxVxSVAhnIHfRxTirSxUwy9iw8WwW77sM992G3YFsA-92Hv8t6n_QNL01P7urUvIIPPe-BSDn0T3eBDenG1UQq36vtOUY73f6Bokw80eGpDJD_bdgwHPvIEiCSmAw</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>Ahn, Chul</creator><creator>Overall, John E</creator><creator>Tonidandel, Scott</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20010201</creationdate><title>Sample size and power calculations in repeated measurement analysis</title><author>Ahn, Chul ; Overall, John E ; Tonidandel, Scott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Biological and medical sciences</topic><topic>Computer simulation</topic><topic>Computerized, statistical medical data processing and models in biomedicine</topic><topic>Controlled Clinical Trials as Topic - statistics & numerical data</topic><topic>Dropouts</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Medical statistics</topic><topic>Numerical analysis</topic><topic>Power calculation</topic><topic>Repeated measures</topic><topic>Sample Size</topic><topic>Sample size estimate</topic><topic>Schizophrenia - drug therapy</topic><topic>Software</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahn, Chul</creatorcontrib><creatorcontrib>Overall, John E</creatorcontrib><creatorcontrib>Tonidandel, Scott</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Computer methods and programs in biomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahn, Chul</au><au>Overall, John E</au><au>Tonidandel, Scott</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sample size and power calculations in repeated measurement analysis</atitle><jtitle>Computer methods and programs in biomedicine</jtitle><addtitle>Comput Methods Programs Biomed</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>64</volume><issue>2</issue><spage>121</spage><epage>124</epage><pages>121-124</pages><issn>0169-2607</issn><eissn>1872-7565</eissn><abstract>Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>11137194</pmid><doi>10.1016/S0169-2607(00)00095-X</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0169-2607 |
ispartof | Computer methods and programs in biomedicine, 2001-02, Vol.64 (2), p.121-124 |
issn | 0169-2607 1872-7565 |
language | eng |
recordid | cdi_proquest_miscellaneous_70583439 |
source | ScienceDirect Journals |
subjects | Biological and medical sciences Computer simulation Computerized, statistical medical data processing and models in biomedicine Controlled Clinical Trials as Topic - statistics & numerical data Dropouts Humans Medical sciences Medical statistics Numerical analysis Power calculation Repeated measures Sample Size Sample size estimate Schizophrenia - drug therapy Software |
title | Sample size and power calculations in repeated measurement analysis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T20%3A54%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sample%20size%20and%20power%20calculations%20in%20repeated%20measurement%20analysis&rft.jtitle=Computer%20methods%20and%20programs%20in%20biomedicine&rft.au=Ahn,%20Chul&rft.date=2001-02-01&rft.volume=64&rft.issue=2&rft.spage=121&rft.epage=124&rft.pages=121-124&rft.issn=0169-2607&rft.eissn=1872-7565&rft_id=info:doi/10.1016/S0169-2607(00)00095-X&rft_dat=%3Cproquest_cross%3E525577%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18642500&rft_id=info:pmid/11137194&rfr_iscdi=true |